AVITA Medical (RCEL) Invested Capital (2019 - 2025)

AVITA Medical has reported Invested Capital for 7 years, with the latest figure at $26.3 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 485.33% year-over-year to $26.3 million; the trailing twelve-month figure through Dec 2025 stood at $26.3 million (up 485.33% YoY), and the FY2025 full-year result was $26.3 million, up 485.33% from the prior year.
• Invested Capital for Q4 2025 stood at $26.3 million, down from $35.8 million in the prior quarter.
• The five-year high for Invested Capital was $118.9 million in Q1 2021, with the low at -$9.9 million in Q2 2025.
• Historically, Invested Capital has averaged $59.8 million across 5 years, with a median of $65.8 million in 2023.
• The largest YoY upside for Invested Capital was 485.33% in 2025 against a maximum downside of 141.36% in 2025.
• AVITA Medical's Invested Capital stood at $104.6 million in 2021, then slipped by 19.01% to $84.7 million in 2022, then tumbled by 42.11% to $49.1 million in 2023, then slumped by 90.83% to $4.5 million in 2024, then jumped by 485.33% to $26.3 million in 2025.
• The last three Invested Capital figures came in at $26.3 million (Q4 2025), $35.8 million (Q3 2025), and -$9.9 million (Q2 2025), per Business Quant data.